| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |